Lung Cancer

1

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma

De Grève, Jacques, Moran, Teresa, Graas, Marie-Pascale, Galdermans, Daniella, Vuylsteke, Peter, Canon, Jean-Luc, Schallier, Denis, Decoster, Lore, Teugels, Erik, Massey, Dan, Chand, Vikram K., Vanstee

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 506 KB

english, 2015

2

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers

Rangachari, Deepa, Yamaguchi, Norihiro, VanderLaan, Paul A., Folch, Erik, Mahadevan, Anand, Floyd, Scott R., Uhlmann, Erik J., Wong, Eric T., Dahlberg, Suzanne E., Huberman, Mark S., Costa, Daniel B.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 393 KB

english, 2015

3

Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma

Wieckowski, Sébastien, Hemmerle, Teresa, Prince, Spasenja Savic, Schlienger, Béatrice Dolder, Hillinger, Sven, Neri, Dario, Zippelius, Alfred

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 3.16 MB

english, 2015

4

CT screening for lung cancer: Importance of emphysema for never smokers and smokers

Henschke, Claudia I., Yip, Rowena, Boffetta, Paolo, Markowitz, Steven, Miller, Albert, Hanaoka, Takaomi, Wu, Ning, Zulueta, Javier J., Yankelevitz, David F.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 410 KB

english, 2015

5

Role of surgical resection for patients with limited disease-small cell lung cancer

Takenaka, Tomoyoshi, Takenoyama, Mitsuhiro, Inamasu, Eiko, Yoshida, Tsukihisa, Toyokawa, Gouji, Nosaki, Kaname, Hirai, Fumihiko, Yamaguchi, Masafumi, Shimokawa, Mototsugu, Seto, Takashi, Ichinose, Yuk

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 947 KB

english, 2015

6

HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas

Reis, H., Herold, T., Ting, S., Worm, K., Huber, U., Christoph, D.C., Eberhardt, W.E., Kostbade, K., Kasper, S., Stamatis, G., Welter, S., Darwiche, K., Karpf-Wissel, R., Theegarten, D., Schmid, K.W.,

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.04 MB

english, 2015

7

Clinical outcomes in patients with small cell lung cancer in a single institute: Comparative analysis of radiographic screening with symptom-prompted patients

Fukushima, Toshirou, Tateishi, Kazunari, Hanaoka, Masayuki, Koizumi, Tomonobu

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 372 KB

english, 2015

8

Does lung cancer attract greater stigma than other cancer types?

Marlow, Laura A.V., Waller, Jo, Wardle, Jane

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 556 KB

english, 2015

9

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors

Le, Xiuning, Desai, Neelam V., Majid, Adnan, Karp, Rebecca S., Huberman, Mark S., Rangachari, Deepa, Kent, Michael S., Gangadharan, Sidharta P., Folch, Erik, VanderLaan, Paul A., Costa, Daniel B.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.48 MB

english, 2015

10

Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis

Steuer, Conor E., Behera, Madhusmita, Kim, Sungjin, Patel, Nikita, Chen, Zhengjia, Pillai, Rathi, Saba, Nabil F., Shin, Dong M., Owonikoko, Taofeek K., Khuri, Fadlo R., Ramalingam, Suresh S.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 361 KB

english, 2015

11

Second primary lung cancers following a diagnosis of primary head and neck cancer

Griffioen, Gwendolyn H.M.J., Louie, Alexander V., de Bree, Remco, Smit, Egbert F., Paul, Marinus A., Slotman, Ben J., Leemans, C. Rene, Senan, Suresh

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 576 KB

english, 2015

12

Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal

Togashi, Yosuke, Hayashi, Hidetoshi, Okamoto, Kunio, Fumita, Soichi, Terashima, Masato, de Velasco, Marco A., Sakai, Kazuko, Fujita, Yoshihiko, Tomida, Shuta, Nakagawa, Kazuhiko, Nishio, Kazuto

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.24 MB

english, 2015

13

Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers

Kim, Moon-Young, Koh, Jaemoon, Kim, Sehui, Go, Heounjeong, Jeon, Yoon Kyung, Chung, Doo Hyun

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 3.33 MB

english, 2015

14

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis

Kravchenko, Julia, Berry, Mark, Arbeev, Konstantin, Kim Lyerly, H., Yashin, Anatoly, Akushevich, Igor

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 652 KB

english, 2015

15

Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG)

Kotsakis, A., Kentepozidis, N., Emmanouilidis, Ch., Polyzos, A., Agelidou, A., Vaslamatzis, M., Chandrinos, V., Agelaki, S., Vamvakas, L., Kalbakis, K., Katsaounis, P., Stoltidis, D., Nintos, G., Hatz

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 488 KB

english, 2015

16

Preferences for disclosure of disease related information among thoracic cancer patients

Sella, Tal, Botser, Dana, Navon, Rossie, Biran, Haim, Tenenbaum, Shiri, Urban, Damien, Onn, Amir, Bar, Jair

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 312 KB

english, 2015

17

Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer

Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 772 KB

english, 2015

18

Referral patterns for mediastinal staging with EBUS across a UK Lung Cancer Network

Evison, Matthew, Crosbie, Philip, Morris, Julie, Martin, Julie, Shah, Rajesh, Doran, Helen, Hoyle, Jennifer, Bailey, Simon, Rana, Durgesh, Sundar, Ram, Booton, Richard

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 191 KB

english, 2015

19

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

Li, Heyan, Wang, Shuo, Takayama, Koichi, Harada, Taishi, Okamoto, Isamu, Iwama, Eiji, Fujii, Akiko, Ota, Keiichi, Hidaka, Noriko, Kawano, Yuko, Nakanishi, Yoichi

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.66 MB

english, 2015

20

Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer

Koizumi, Tomonobu, Fukushima, Toshirou, Tatai, Toshiharu, Kobayashi, Takashi, Sekiguchi, Nodoka, Sakamoto, Akiyuki, Sasaki, Shigeru

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 228 KB

english, 2015

21

Editorial Board

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 67 KB

english, 2015

Volume 88; Issue 1

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers

Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma

CT screening for lung cancer: Importance of emphysema for never smokers and smokers

Role of surgical resection for patients with limited disease-small cell lung cancer

HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas

Clinical outcomes in patients with small cell lung cancer in a single institute: Comparative analysis of radiographic screening with symptom-prompted patients

Does lung cancer attract greater stigma than other cancer types?

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors

Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis

Second primary lung cancers following a diagnosis of primary head and neck cancer

Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal

Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis

Preferences for disclosure of disease related information among thoracic cancer patients

Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer

Referral patterns for mediastinal staging with EBUS across a UK Lung Cancer Network

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer

Contents

Editorial Board